clinical trial · NCT06423352
A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension
Mild to Moderate HypertensionZilebesiranPlacebo
brief summary
The purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacodynamics (PD) and pharmacokinetics (PK) of zilebesiran in Japanese patients with mild to moderate hypertension.
started
Jun 5, 2024
primary completion
Jul 17, 2025
completion
Jul 17, 2025
last updated
Apr 30, 2026
official title
A Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacodynamics, and Pharmacokinetics of Zilebesiran in Japanese Patients With Mild to Moderate Hypertension
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol